Optimising the treatment of upper gastrointestinal fistulae

Gut

Volumn 49, Issue SUPPL. 4, 2001, Pages

  Gonzalez Pinto I ^a   Moreno Gonzalez E ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN 14;

ABDOMINAL DRAINAGE; ABDOMINAL SURGERY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BILE DUCT FISTULA; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DIGESTIVE SYSTEM FISTULA; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; ELECTROLYTE BALANCE; FLUID THERAPY; GASTROINTESTINAL RADIOGRAPHY; HUMAN; IATROGENIC DISEASE; INCIDENCE; INTESTINE FISTULA; NUTRITIONAL SUPPORT; PANCREAS FISTULA; PANCREAS SURGERY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN CARE; TOTAL PARENTERAL NUTRITION; WOUND CARE;

ANTI-BACTERIAL AGENTS; DRAINAGE; FLUID THERAPY; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL FISTULA; NUTRITIONAL SUPPORT; POSTOPERATIVE COMPLICATIONS; WOUND HEALING;

EID: 17644447126     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. The pathophysiology of enterocutaneous fistulas
2. Radiation-induced gastrointestinal fistulae
3. Complication of prolonged transpyloric feeding: Formation of an enterocutaneous fistula
4. Free perforation of benign gastrojejunocolic fistula. Report of two cases
5. Intestinal surgery in gynecologic oncology
6. Smoking in Crohn's disease: Effect on localisation and clinical course
7. Late effects of radiation therapy on the gastrointestinal tract
8. Classification and pathophysiology of enterocutaneous fistulas
9. Pathophysiology and therapy of chronic radiation-induced injury to the colon
10. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Pathology, complications, and outcomes
11. Pancreatic cancer in 1988. Possibilities and probabilities
12. Octreotide in preventing complications of pancreatic surgery. Octreotide: From basic science to clinical medicine
13. General management of gastrointestinal fistulas. Recognition, stabilization, and correction of fluid and electrolyte imbalances
14. Radiologic investigation and treatment of gastrointestinal fistulas
15. Enterocutaneous fistulae: Interventional radiologic management
16. Reappraisal of contrast media used to detect upper gastrointestinal perforations: Comparison of ionic water-soluble media with barium sulfate
17. Pancreatic cutaneous fistulas
18. Treatment of pancreatic ascites and external pancreatic fistulas with a long-acting somatostatin analogue (Sandostatin)
19. Treatment of pancreatic cutaneous fistulas with a somatostatin analog
20. Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin
21. Treatment of enterocutaneous fistulas with TPN and somatostatin, compared with patients who received TPN only
22. Management of post-operative enterocutaneous fistulas: The roles of parenteral nutrition and surgery
23. Review of 404 patients with gastrointestinal fistulas. Impact of parenteral nutrition
24. Artificial nutritional support in patients with gastrointestinal fistulas
25. Internal pancreatic fistula
26. Reoperative versus conservative management for gastrointestinal fistulas
27. Principles of operative surgery. Antisepsis, techniques, sutures, and drains
28. Closed suction wide area drainage
29. Percutaneous drainage of intra-abdominal abscesses following abdominal trauma
30. Skin care management of gastrointestinal fistulas
31. Management of the enterocutaneous fistula (continuous education credit)
32. Fistulas of the upper gastrointestinal tract
33. External intestinal fistulae in Port Harcourt
34. Faecal fistulae in children
35. Enteral versus parenteral nutrition after oesophagogastric surgery: A prospective randomised comparison
36. Factors influencing outcome in patients with gastrointestinal fistula
37. Gastro-intestinal fistulas: The role of nutritional support
38. Nutritional management of patients with gastrointestinal fistulas
39. Postoperative total parenteral nutrition
40. High-output external fistulae of the small bowel: Management with continuous enteral nutrition
41. The effect of total parenteral nutrition or elemental diet on pancreatic proteolytic activity and ultrastructure
42. Treatment of external gastrointestinal fistulas by a combination of total parenteral nutrition and somatostatin
43. Enteral and parenteral nutrition in patients with enteric fistulas and short bowel syndrome
44. Bacterial translocation during enteral and parenteral nutrition
45. Pancreatic exocrine response to parenteral nutrition
46. The role of nutritional support in the management of gastrointestinal fistulas
47. Surgical management and treatment of sepsis associated with gastrointestinal fistulas
48. Factors influencing the outcome of treatment of small bowel cutaneous fistula
49. Management of complications following pancreaticoduodenectomy
50. Management of digestive fistulas
51. Verhütung von postoperativen pankreatitischen komplikationen nach duodenopankreatektomie durch somastostatin
52. Somatostatin (two parts)
53. Somatostatin and octreotide: Physiological background and pharmacological application
54. Pharmacokinetics of SMS 201-995 in healthy subjects
55. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial
56. Somatostatin and/or total parenteral nutrition for the treatment of intestinal fistulas
57. Treatment of pancreatic fistulas with somatostatin and total parenteral nutrition
58. Somatostatin analog treatment of pancreatic fistulas
59. Octreotide and postoperative enterocutaneous fistulae: A controlled prospective study
60. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula
61. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small bowel fistula output
62. Treatment of enterocutaneous fistulae with or without octreotide and parenteral nutrition
63. Effects of parenteral hyperalimentation on upper gastrointestinal tract secretions
64. Effects of hypertonic glucose and amino acid infusions on pancreatic exocrine function
65. Somatostatin suppresses secretion and pancreatic exocrine secretion
66. Surgical management of pure pancreatic fistulas
67. Parenteral and enteral nutrition and the enterocutaneous fistula treatment. II. Factors influencing the outcome of treatment
68. Role of octreotide and somatostatin in the treatment of intestinal fistulae
69. Adjuvant therapy with somatostatin i.v. in post-operative fistulae of the pancreas, gall bladder and small intestine. A multicentre, randomised study
70. Surgical management and treatment of pancreatic fistulas
71. Surgical management and treatment of sepsis associated with gastrointestinal fistulas
72. Pancreatic ascites and effusion. Risk factors for failure of conservative therapy and the role of octreotide
73. Enterocutaneous fistulas
74. The endoscopic diagnosis of ileal colonic fistula and review of literature
75. Surgical management and treatment of gastric and duodenal fistulas
76. Management of bronchobiliary fistula as a late complication of hepatic resection
77. Surgical options in traumatic injury to the extrahepatic biliary tract
78. Endoscopic management of biliary fistula
79. Postoperative bile leakage: Endoscopic management
80. Complicated enterocutaneous fistulas: Failure of octreotide to improve healing
81. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomised placebo-controlled trial